CTOR
Citius Oncology·NASDAQ
--
--(--)
--
--(--)
CTOR fundamentals
Citius Oncology (CTOR) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.08 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.08
--
Report date
Aug 12, 2025
EPS
Actual | -0.09 | -0.11 | -0.08 |
Forecast | -0.06 | -0.09 | -0.15 |
Surprise | -50.00% | -22.22% | +46.67% |
Revenue
Actual | -- | 0 | 0 |
Forecast | 0 | 5.74M | 0 |
Surprise | 0.00% | -100.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Citius Oncology's earnings call?What is the revenue and EPS growth rate for Citius Oncology year over year?What does Citius Oncology do and what are its main business segments?What is the market's earnings forecast for Citius Oncology next quarter?What were the key takeaways from Citius Oncology’s earnings call?What is Citius Oncology's latest dividend and current dividend yield?What factors drove the changes in Citius Oncology's revenue and profit?Did Citius Oncology beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
